SCHEMBL5320307

SCHEMBL5320307

O=C(O)/C=C/c1nn(Cc2ccc(Cl)cc2F)c2cc([N+](=O)[O-])ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 3/20 0.45
GUCY1A1 Q02108 2/20 0.40
GUCY1B1 Q02153 2/20 0.40
SLC22A12 Q96S37 1/20 0.38
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
PMP22 Q01453 1/20 0.36
HIF1A Q16665 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CDK2 P24941 1/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
HTT P42858 2/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CXCR3 P49682 1/20 0.35
CNR1 P21554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5320310 1.00 ENPP2 (0.45) ENPP2GUCY1A1GUCY1B1SLC22A12CYP1A2
SCHEMBL5318021 0.91 ENPP2 (0.40) ENPP2SLC22A12CYP1A2CYP3A4CYP2D6
SCHEMBL5318017 0.91 ENPP2 (0.40) ENPP2SLC22A12CYP1A2CYP3A4CYP2D6
SCHEMBL5317439 0.91 CYP1A2 (0.46) ENPP2SLC22A12CYP1A2CYP3A4CYP2D6
SCHEMBL5317442 0.91 CYP1A2 (0.46) ENPP2SLC22A12CYP1A2CYP3A4CYP2D6
SCHEMBL5320443 0.89 ENPP2 (0.41) ENPP2GUCY1A1GUCY1B1NPSR1CDK2
SCHEMBL5320446 0.89 ENPP2 (0.41) ENPP2GUCY1A1GUCY1B1NPSR1CDK2
SCHEMBL1050572 0.89 ENPP2 (0.54) ENPP2GUCY1A1GUCY1B1SLC22A12CYP1A2
SCHEMBL1050570 0.89 ENPP2 (0.54) ENPP2GUCY1A1GUCY1B1SLC22A12CYP1A2
SCHEMBL5319964 0.89 ENPP2 (0.41) ENPP2GUCY1A1GUCY1B1SLC22A12CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed